These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 35213215)
1. Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries. Yadav K; Cree I; Field A; Vielh P; Mehrotra R JCO Glob Oncol; 2022 Feb; 8():e2100337. PubMed ID: 35213215 [TBL] [Abstract][Full Text] [Related]
2. Screening for cancer in low- and middle-income countries. Sankaranarayanan R Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156 [TBL] [Abstract][Full Text] [Related]
3. Challenges of COVID-19 in children in low- and middle-income countries. Zar HJ; Dawa J; Fischer GB; Castro-Rodriguez JA Paediatr Respir Rev; 2020 Sep; 35():70-74. PubMed ID: 32654854 [TBL] [Abstract][Full Text] [Related]
4. Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? Shah SC; Kayamba V; Peek RM; Heimburger D J Glob Oncol; 2019 Mar; 5():1-8. PubMed ID: 30908147 [TBL] [Abstract][Full Text] [Related]
5. Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group. Villain P; Carvalho AL; Lucas E; Mosquera I; Zhang L; Muwonge R; Selmouni F; Sauvaget C; Basu P; Int J Cancer; 2021 Jul; 149(1):97-107. PubMed ID: 33533501 [TBL] [Abstract][Full Text] [Related]
6. Cytopathology in Low Medical Infrastructure Countries: Why and How to Integrate to Capacitate Health Care. Field AS Clin Lab Med; 2018 Mar; 38(1):175-182. PubMed ID: 29412881 [TBL] [Abstract][Full Text] [Related]
7. Cancer screening and early diagnosis in low and middle income countries : Current situation and future perspectives. Mandal R; Basu P Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1505-1512. PubMed ID: 30353287 [TBL] [Abstract][Full Text] [Related]
8. Pragmatic Recommendations for the Use of Diagnostic Testing and Prognostic Models in Hospitalized Patients with Severe COVID-19 in Low- and Middle-Income Countries. Schultz MJ; Gebremariam TH; Park C; Pisani L; Sivakorn C; Taran S; Papali A; Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):34-47. PubMed ID: 33534752 [TBL] [Abstract][Full Text] [Related]
9. Integrated health service delivery during COVID-19: a scoping review of published evidence from low-income and lower-middle-income countries. Hasan MZ; Neill R; Das P; Venugopal V; Arora D; Bishai D; Jain N; Gupta S BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34135071 [TBL] [Abstract][Full Text] [Related]
10. Systematic review of laparoscopic surgery in low- and middle-income countries: benefits, challenges, and strategies. Chao TE; Mandigo M; Opoku-Anane J; Maine R Surg Endosc; 2016 Jan; 30(1):1-10. PubMed ID: 25875087 [TBL] [Abstract][Full Text] [Related]
11. Interventions Addressing Barriers to Delayed Cancer Diagnosis in Low- and Middle-Income Countries: A Systematic Review. Qu LG; Brand NR; Chao A; Ilbawi AM Oncologist; 2020 Sep; 25(9):e1382-e1395. PubMed ID: 32125732 [TBL] [Abstract][Full Text] [Related]
12. Challenges in the management of colorectal cancer in low- and middle-income countries. Khan SZ; Lengyel CG Cancer Treat Res Commun; 2023; 35():100705. PubMed ID: 37060879 [TBL] [Abstract][Full Text] [Related]
13. The COVID-19 pandemic has impeded cytopathology practices and hindered cancer screening and management. Huang CY; Chen CC Cytopathology; 2023 Sep; 34(5):406-416. PubMed ID: 37332230 [TBL] [Abstract][Full Text] [Related]
14. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism. Amanpour S Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952 [TBL] [Abstract][Full Text] [Related]
15. Health Systems Approach to Ensure Quality and Safety Amid COVID-19 Pandemic in Pakistan. Pradhan NA; Feroz AS; Shah SM J Coll Physicians Surg Pak; 2021 Jan; 31(1):S38-S41. PubMed ID: 33650424 [TBL] [Abstract][Full Text] [Related]